- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06965426
- Original Trial
Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
August 28, 2026 updated by: Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ryan Powell, OD
- Phone Number: 8165319100
- Email: drpowell@vseyecare.com
Study Contact Backup
- Name: Crystal Remington, OD
- Phone Number: 8165319100
- Email: drremington@vseyecare.com
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- Recruiting
- Vision Source
-
Contact:
- Crystal Remington Remington, OD
- Phone Number: 816-531-9100
- Email: drremington@vseyecare.com
-
Contact:
- Ryan Powell Powell, OD
- Phone Number: 8164764017
- Email: drpowell@vseyecare.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adult patients 18-50 years old of any sex and any race.
- Willing to comply with the protocol instructions.
- Has read (or has had read to), understood, and signed an Informed Consent.
Exclusion Criteria:
- Current Smoker
- Pregnant, plan to become pregnant or breastfeeding
- History of any non-controlled disease states including diabetes, cancer, heart diseases ETC (we need to confirm this with previous protocols) BMI greater than 30
- Currently taking MacuHealth or similar supplements or previous use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Other Names:
|
|
Active Comparator: MacuHealth Supplementation
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
|
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Carotenoid concentration
Time Frame: 6 months
|
Change in skin carotenoid concentration over supplementation vs. placebo exposure durations.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2025
Primary Completion (Estimated)
October 29, 2026
Study Completion (Estimated)
December 29, 2026
Study Registration Dates
First Submitted
May 2, 2025
First Submitted That Met QC Criteria
May 2, 2025
First Posted (Actual)
May 11, 2025
Study Record Updates
Last Update Posted (Actual)
September 1, 2026
Last Update Submitted That Met QC Criteria
August 28, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Eye Diseases
- Retinal Diseases
- Retinal Degeneration
- Macular Degeneration
- Organic Chemicals
- Carotenoids
- Polyenes
- Alkenes
- Hydrocarbons, Acyclic
- Hydrocarbons
- Cyclohexenes
- Cyclohexanes
- Cycloparaffins
- Hydrocarbons, Alicyclic
- Hydrocarbons, Cyclic
- Terpenes
- Pigments, Biological
- Biological Factors
- Xanthophylls
- Lutein
- Zeaxanthins
Other Study ID Numbers
- VSE001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.